eGene Inc. Plan To Launch Complete Solution For Fast And Low-Cost Bird Flu Screening Through Distribution Agreement With Veredus Laboratories, Singapore For Its AIV-H5N1 PCR Kit Using eGene's HDA-GT12 System  
1/29/2007 2:37:36 PM

IRVINE, Calif.--(BUSINESS WIRE)--eGene Inc. (OTCBB:EGEI), developer of a revolutionary high-performance genetic analysis technology, today announced that it plans to launch a complete solution for fast and low-cost bird flu screening by entering into a distribution agreement with Veredus Labs, Singapore for AIV-H5N1 PCR Kit Using eGene’s HDA-GT12 System.